Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibody

Vern L. Katz; John M. Thorp; William J. Watson; Larry Fowler; R. Phillip Heine

doi:10.1097/00006250-199011000-00071

Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibody

Vern L. Katz, John M. Thorp, William J. Watson, Larry Fowler, R. Phillip Heine

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Abstract

A patient with lupus anticoagulant and anticardiolipin anti-body developed preeclampsia at 24 weeks’ gestation. Therapy with human immunoglobulin (Ig) resulted in stabilization of preeclampsia and suppression of the lupus anticoagulant. Anticardiolipin antibody titers were partially suppressed. Preeclampsia worsened at 32 weeks’ gestation, and a healthy infant was delivered. For patients with preeclampsia secondary to lupus anticoagulant before the fetus is viable, human Ig is a potential therapeutic option.

Original language	English (US)
Pages (from-to)	986-988
Number of pages	3
Journal	Obstetrics and gynecology
Volume	76
Issue number	5
DOIs	https://doi.org/10.1097/00006250-199011000-00071
State	Published - Nov 1990
Externally published	Yes

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1097/00006250-199011000-00071

Cite this

@article{f8d5b670a92b42ea8482c3f1b30f55f7,

title = "Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibody",

abstract = "A patient with lupus anticoagulant and anticardiolipin anti-body developed preeclampsia at 24 weeks{\textquoteright} gestation. Therapy with human immunoglobulin (Ig) resulted in stabilization of preeclampsia and suppression of the lupus anticoagulant. Anticardiolipin antibody titers were partially suppressed. Preeclampsia worsened at 32 weeks{\textquoteright} gestation, and a healthy infant was delivered. For patients with preeclampsia secondary to lupus anticoagulant before the fetus is viable, human Ig is a potential therapeutic option.",

author = "Katz, {Vern L.} and Thorp, {John M.} and Watson, {William J.} and Larry Fowler and Heine, {R. Phillip}",

year = "1990",

month = nov,

doi = "10.1097/00006250-199011000-00071",

language = "English (US)",

volume = "76",

pages = "986--988",

journal = "Obstetrics and Gynecology",

issn = "0029-7844",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibody

AU - Katz, Vern L.

AU - Thorp, John M.

AU - Watson, William J.

AU - Fowler, Larry

AU - Heine, R. Phillip

PY - 1990/11

Y1 - 1990/11

N2 - A patient with lupus anticoagulant and anticardiolipin anti-body developed preeclampsia at 24 weeks’ gestation. Therapy with human immunoglobulin (Ig) resulted in stabilization of preeclampsia and suppression of the lupus anticoagulant. Anticardiolipin antibody titers were partially suppressed. Preeclampsia worsened at 32 weeks’ gestation, and a healthy infant was delivered. For patients with preeclampsia secondary to lupus anticoagulant before the fetus is viable, human Ig is a potential therapeutic option.

AB - A patient with lupus anticoagulant and anticardiolipin anti-body developed preeclampsia at 24 weeks’ gestation. Therapy with human immunoglobulin (Ig) resulted in stabilization of preeclampsia and suppression of the lupus anticoagulant. Anticardiolipin antibody titers were partially suppressed. Preeclampsia worsened at 32 weeks’ gestation, and a healthy infant was delivered. For patients with preeclampsia secondary to lupus anticoagulant before the fetus is viable, human Ig is a potential therapeutic option.

UR - http://www.scopus.com/inward/record.url?scp=0025048975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025048975&partnerID=8YFLogxK

U2 - 10.1097/00006250-199011000-00071

DO - 10.1097/00006250-199011000-00071

M3 - Article

C2 - 2120649

AN - SCOPUS:0025048975

VL - 76

SP - 986

EP - 988

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5

ER -

Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibody

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this